Ye Z, Ng C, Liu H, Bao Q, Xu S, Zu D
Theranostics. 2024; 14(9):3423-3438.
PMID: 38948056
PMC: 11209707.
DOI: 10.7150/thno.93127.
Loh A, Thura M, Gupta A, Tan S, Kuan K, Ang K
Mol Ther Oncolytics. 2023; 30:153-166.
PMID: 37674627
PMC: 10477756.
DOI: 10.1016/j.omto.2023.08.006.
Chia P, Ang K, Thura M, Zeng Q
Theranostics. 2023; 13(6):1876-1891.
PMID: 37064866
PMC: 10091880.
DOI: 10.7150/thno.79265.
Li C, Tsai H, Chen Y, Wang C, Lin Y, Chu P
J Hepatocell Carcinoma. 2023; 10:123-138.
PMID: 36741246
PMC: 9896975.
DOI: 10.2147/JHC.S385238.
Ryu K, Yoshida A, Funato Y, Yamazaki D, Miki H
Cell Struct Funct. 2022; 47(2):75-87.
PMID: 36336348
PMC: 10511051.
DOI: 10.1247/csf.22034.
PTP4A2 promotes lysophagy by dephosphorylation of VCP/p97 at Tyr805.
Bai Y, Yu G, Zhou H, Amarasinghe O, Zhou Y, Zhu P
Autophagy. 2022; 19(5):1562-1581.
PMID: 36300783
PMC: 10240998.
DOI: 10.1080/15548627.2022.2140558.
Phosphatase-independent role of phosphatase of regenerating liver in cancer progression.
Funato Y, Hashizume O, Miki H
Cancer Sci. 2022; 114(1):25-33.
PMID: 36285487
PMC: 9807511.
DOI: 10.1111/cas.15625.
Characterizing /PRL-3 as the Potential Prognostic Marker Gene for Liver Hepatocellular Carcinoma.
Jin X, Shi H, Li Z, Li H, Ma H, Shi X
J Oncol. 2022; 2022:2717056.
PMID: 36213837
PMC: 9546693.
DOI: 10.1155/2022/2717056.
RP5-1148A21.3 (lncRP5) exerts oncogenic function in human ovarian carcinoma.
Sun P, Bao A, Hua X, Cao J, Ding Y
Acta Biochim Biophys Sin (Shanghai). 2022; 54(2):209-219.
PMID: 35538027
PMC: 9909314.
DOI: 10.3724/abbs.2022002.
Potential of Farnesyl Transferase Inhibitors in Combination Regimens in Squamous Cell Carcinomas.
Kessler L, Malik S, Leoni M, Burrows F
Cancers (Basel). 2021; 13(21).
PMID: 34771475
PMC: 8582567.
DOI: 10.3390/cancers13215310.
RNA-Seq analysis in giant pandas reveals the differential expression of multiple genes involved in cataract formation.
You Y, Bai C, Liu X, Lu Y, Jia T, Xia M
BMC Genom Data. 2021; 22(1):44.
PMID: 34706646
PMC: 8555103.
DOI: 10.1186/s12863-021-00996-x.
Increased Phosphatase of Regenerating Liver-1 by Placental Stem Cells Promotes Hepatic Regeneration in a Bile-Duct-Ligated Rat Model.
Choi J, Park S, Kim G, Kim J, Jun J, Bae S
Cells. 2021; 10(10).
PMID: 34685509
PMC: 8533985.
DOI: 10.3390/cells10102530.
PRL3 induces polypoid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse.
Thura M, Ye Z, Al-Aidaroos A, Xiong Q, Ong J, Gupta A
Commun Biol. 2021; 4(1):923.
PMID: 34326464
PMC: 8322210.
DOI: 10.1038/s42003-021-02449-8.
A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3).
Rivas D, Dela Cerna M, Smith C, Sampathi S, Patty B, Lee D
Sci Rep. 2021; 11(1):10302.
PMID: 33986418
PMC: 8119466.
DOI: 10.1038/s41598-021-89668-5.
Mesenchymal and Phosphatase of Regenerating Liver-3 Status in Circulating Tumor Cells May Serve as a Crucial Prognostic Marker for Assessing Relapse or Metastasis in Postoperative Patients With Colorectal Cancer.
Su P, Lai W, Liu L, Zeng Y, Xu H, Lan Q
Clin Transl Gastroenterol. 2021; 11(12):e00265.
PMID: 33512811
PMC: 7743843.
DOI: 10.14309/ctg.0000000000000265.
PRL3-DDX21 Transcriptional Control of Endolysosomal Genes Restricts Melanocyte Stem Cell Differentiation.
Johansson J, Marie K, Lu Y, Brombin A, Santoriello C, Zeng Z
Dev Cell. 2020; 54(3):317-332.e9.
PMID: 32652076
PMC: 7435699.
DOI: 10.1016/j.devcel.2020.06.013.
PRL3 pseudophosphatase activity is necessary and sufficient to promote metastatic growth.
Kozlov G, Funato Y, Chen Y, Zhang Z, Illes K, Miki H
J Biol Chem. 2020; 295(33):11682-11692.
PMID: 32571875
PMC: 7450121.
DOI: 10.1074/jbc.RA120.014464.
Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) drives migration and progression of T-cell acute lymphoblastic leukemia in vitro and in vivo.
Wei M, Haney M, Rivas D, Blackburn J
Oncogenesis. 2020; 9(1):6.
PMID: 32001668
PMC: 6992623.
DOI: 10.1038/s41389-020-0192-5.
Non-canonical activation of β-catenin by PRL-3 phosphatase in acute myeloid leukemia.
Chong P, Zhou J, Chooi J, Chan Z, Toh S, Tan T
Oncogene. 2018; 38(9):1508-1519.
PMID: 30305722
DOI: 10.1038/s41388-018-0526-3.
Chemotherapy induced PRL3 expression promotes cancer growth via plasma membrane remodeling and specific alterations of caveolae-associated signaling.
Csoboz B, Gombos I, Tatrai E, Tovari J, L Kiss A, Horvath I
Cell Commun Signal. 2018; 16(1):51.
PMID: 30157875
PMC: 6116440.
DOI: 10.1186/s12964-018-0264-8.